文献速递肝病

HIV感染者中脂肪肝与肝纤维化负担:一项美国多中心横断面研究

Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study.
PubMed 文献 · Hepatology · 2023-02-22

在美国3个中心对342例HIV感染者进行前瞻性横断面评估,采用肝脏超声和振动控制瞬时弹性成像检测脂肪肝与肝纤维化。超声脂肪肝患病率48.7%,NAFLD占脂肪肝的90%;脂肪肝患者中临床显著纤维化和进展期纤维化分别占约五分之一和6%。

要点

  • 病毒学抑制的HIV感染者中近半数存在脂肪肝,其中90%为NAFLD。
  • 脂肪肝患者中约五分之一有临床显著纤维化,6%有进展期纤维化。
  • 老年、较高BMI、糖尿病和较高ALT与NAFLD风险独立相关。

核心结论

  • 病毒学抑制的HIV感染者中近半数有脂肪肝,其中90%由NAFLD所致。
  • 脂肪肝的HIV感染者中五分之一有临床显著纤维化,6%有进展期纤维化。
  • 这些数据支持对HIV感染者中高危NAFLD进行系统筛查。

研究设计与样本

  • 美国3个中心HIV门诊的前瞻性横断面研究,共纳入342例同意参与的HIV感染者。
  • 采用肝脏超声和振动控制瞬时弹性成像检测受控衰减参数与肝硬度值。
  • 使用单变量和多变量逻辑回归模型评估与NAFLD风险相关的因素。

主要发现

  • 342例中95.6%正在接受抗逆转录病毒治疗,93.9%病毒学抑制充分。
  • 超声诊断脂肪肝占48.7%(95%CI 43%-54%),受控衰减参数≥263 dB/m诊断脂肪肝占50.6%(95%CI 45%-56%)。
  • NAFLD占脂肪肝的90%。
  • 多变量分析中,老年、较高体重指数、糖尿病和较高丙氨酸氨基转移酶与NAFLD风险增高独立相关,而抗逆转录病毒治疗或CD4+细胞计数无此关联。
  • 全部脂肪肝的HIV感染者中,肝硬度值8-12 kPa占13.9%(95%CI 9%-20%),≥12 kPa占6.4%(95%CI 3%-11%),NAFLD中这些肝硬度值切点的频率相似。

临床怎么用

  • 作者认为这些数据支持对HIV感染者中高危NAFLD进行系统筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AIMS: The current prevalence of fatty liver disease (FLD) due to alcohol-associated (AFLD) and nonalcoholic (NAFLD) origins in US persons with HIV (PWH) is not well defined. We prospectively evaluated the burden of FLD and hepatic fibrosis in a diverse cohort of PWH. APPROACH RESULTS: Consenting participants in outpatient HIV clinics in 3 centers in the US underwent detailed phenotyping, including liver ultrasound and vibration-controlled transient elastography for controlled attenuation parameter and liver stiffness measurement. The prevalence of AFLD, NAFLD, and clinically significant and advanced fibrosis was determined. Univariate and multivariate logistic regression models were used to evaluate factors associated with the risk of NAFLD. Of 342 participants, 95.6% were on antiretroviral therapy, 93.9% had adequate viral suppression, 48.7% (95% CI 43%-54%) had steatosis by ultrasound, and 50.6% (95% CI 45%-56%) had steatosis by controlled attenuation parameter ≥263 dB/m. NAFLD accounted for 90% of FLD. In multivariable analysis, old age, higher body mass index, diabetes, and higher alanine aminotransferase, but not antiretroviral therapy or CD4 + cell count, were independently associated with increased NAFLD risk. In all PWH with fatty liver, the frequency of liver stiffness measurement 8-12 kPa was 13.9% (95% CI 9%-20%) and ≥12 kPa 6.4% (95% CI 3%-11%), with a similar frequency of these liver stiffness measurement cutoffs in NAFLD. CONCLUSIONS: Nearly half of the virally-suppressed PWH have FLD, 90% of which is due to NAFLD. A fifth of the PWH with FLD has clinically significant fibrosis, and 6% have advanced fibrosis. These data lend support to systematic screening for high-risk NAFLD in PWH.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Gawrieh S, Lake JE, Debroy P, et al. Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study. Hepatology. 2023. PMID: 36805976. doi:10.1097/HEP.0000000000000313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。